ARTICLE | Company News
Sangamo, Sigma-Aldrich, Roche deal
July 14, 2008 7:00 AM UTC
Roche received a non-exclusive, worldwide license to Sangamo’s zinc finger nuclease (ZFN) technology and an option to obtain an exclusive, worldwide license to commercialize therapeutics and diagnosti...